Kiadis Pharma   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Amsterdam Netherlands (1997)
Status: Acquired by Sanofi-Aventis (2020)

Organization Overview

First Clinical Trial
2005
NCT00993486
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kiadis Pharma